Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maria Calaminici
Programmed Cell Death Protein-1 (PD1) Expression in the Microenvironment of Classical Hodgkin Lymphoma Is Similar Between Favorable and Adverse Outcome and Does Not Enrich Over Serial Relapses With Conventional Chemotherapy
Haematologica
Hematology
Related publications
HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Classical Hodgkin Lymphoma With Reduced 2m/MHC Class I Expression Is Associated With Inferior Outcome Independent of 9p24.1 Status
Cancer immunology research
Cancer Research
Immunology
More Chemotherapy Does Not Obviate the Need for Radiation Therapy (RT): Treatment for Early-Stage Favorable Hodgkin Lymphoma According to the HD10 Trial Compared With Chemotherapy Alone
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Human Germinal Center-Associated Lymphoma Protein Expression Is Associated With Improved Failure-Free Survival in Brazilian Patients With Classical Hodgkin Lymphoma
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Increased Programmed Death-1 Expression on CD4+ T Cells in Cutaneous T-Cell Lymphoma
Archives of Dermatology
Catching Up With Solid Tumor Oncology: What Is the Evidence for a Prognostic Role of Programmed Cell Death-Ligand 1/Programmed Cell Death-1 Expression in B-Cell Lymphomas?
Haematologica
Hematology
Expression of PD-1 and PD-L1 Increase in Consecutive Biopsies in Patients With Classical Hodgkin Lymphoma
PLoS ONE
Multidisciplinary
Higher Programmed Cell Death 1 Ligand 1 (PD-L1) mRNA Level in Clear Cell Renal Cell Carcinomas Is Associated With a Favorable Outcome Due to the Active Immune Responses in Tumor Tissues
Oncotarget
Oncology
Programmed Death Ligand 1 in Non-Clear Cell Renal Cell Carcinoma and Correlation With Tumor Microenvironment and Prognostic Factors
Medical Journal of Islamic World Academy of Sciences
